This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Pre-Market Pulse: Dendreon, Novartis AG, Stryker, And Repros Therapeutics

LONDON, January 15, 2014 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

On Tuesday, January 14, 2014, the U.S. equity market finished on a positive note. The S&P 500 ended the day at 1,838.88, up 1.08%; the Dow Jones Industrial Average closed at 16,373.86, up 0.71%; and the NASDAQ Composite Index finished at 4,183.02, up 1.69%. The S&P 500 Health Care Sector Index gained 1.28% to close the session at 660.32; and the same has gained 10.62% in the previous three months and 6.32% in the last one month, outperforming the S&P 500, which has gained 7.53% and 3.58% during the respective periods. The major movers in the Health Care Sector included Dendreon Corp. (NASDAQ: DNDN), Novartis AG (NYSE: NVS), Stryker Corp. (NYSE: SYK), and Repros Therapeutics Inc. (NASDAQ: RPRX). All these companies are tracked by AAAResearchReports.com. Download free technical analysis and charting reports on DNDN, NVS, SYK, and RPRX now at:

http://www.aaaresearchreports.com/register/

On Tuesday, Dendreon Corp.'s stock closed the day at $3.30, up 1.23% from the previous day's closing price of $3.26. The company's shares vacillated between $3.21 and $3.40 during the trading session. A total of 5.05 million shares were traded, which is above the daily average volume of 4.66 million. The company's shares have surged 25.00% in the previous three months and 13.40% in the last three trading sessions, outperforming the S&P 500, which has gained 7.53% and 0.04% during the respective periods. Additionally, Dendreon Corp.'s stock is trading above its 50-day moving average of $2.93. Download free research on DNDN today by registering at:

http://www.AAAResearchReports.com/DNDN011514.pdf

Novartis AG's stock edged 0.44% higher on Tuesday, ending the day at $80.74, after oscillating between $80.39 and $80.94 during the trading session. A total of 0.89 million shares were traded, which is below the daily average volume 1.29 million. The company's shares have advanced 5.08% in the previous one month, outperforming the S&P 500, which has gained 3.58% during the same period. Moreover, Novartis AG's stock is trading near its 52-week high of $81.37 and also above its 50-day and 200-day moving averages of $78.60 and $74.88, respectively. Sign up and have access to our free report on NVS at:

http://www.AAAResearchReports.com/NVS011514.pdf

Shares in Stryker Corp. fluctuated between $77.48 and $78.40 before closing the Tuesday's trading session at $78.16, up 0.94%. A total of 1.57 million shares were traded, which is above the daily average volume of 1.36 million. The company's shares have gained 10.38% in the previous three months and 9.22% in the last one month, outperforming the S&P 500, which has gained 7.53% and 3.58% during the respective periods. Furthermore, shares in Stryker Corp. are trading near their 52-week high of $78.53 and also above their 50-day and 200-day moving averages of $74.28 and $69.73, respectively. Sign up and read the complimentary report on SYK at:

http://www.AAAResearchReports.com/SYK011514.pdf

On Tuesday, Repros Therapeutics Inc.'s stock closed the day at $20.43, up 1.79% from the previous day's closing price of $20.07. The company's shares vacillated between $19.86 and $20.57 during the trading session. A total of 0.21 million shares were traded, which is below the daily average volume of 0.50 million. The company's shares have gained 18.92% in the previous one month and 0.20% in the last three trading sessions, outperforming the S&P 500, which has gained 3.58% and 0.04% during the respective periods. Further, Repros Therapeutics Inc.'s stock is trading above its 50-day and 200-day moving averages of $17.21 and $19.35, respectively. The free report on RPRX can be downloaded by signing up now at:

http://www.AAAResearchReports.com/RPRX011514.pdf

----

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,039.49 +60.36 0.36%
S&P 500 1,992.37 +5.86 0.30%
NASDAQ 4,532.1040 +5.6220 0.12%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs